What does the presence of hemoglobin E on hemoglobin electrophoresis indicate?

Hemoglobin E on Hemoglobin Analysis: Clinical Significance

The presence of hemoglobin E (HbE) on hemoglobin electrophoresis indicates a common hemoglobinopathy, most prevalent in Southeast Asian populations, where clinical significance depends entirely on the genetic state: heterozygotes (HbE trait) are essentially asymptomatic with mild microcytosis, homozygotes (HbEE) have minimal anemia, but compound heterozygotes with β-thalassemia (HbE/β-thal) can present with severe transfusion-dependent anemia.

Understanding the Genetic States

When HbE appears on hemoglobin analysis, you must determine which of three genetic states exists:

HbE Heterozygotes (HbE Trait)

• Clinically benign condition with low-normal hemoglobin levels (mean ~122.7 g/L) and mild microcytosis (MCV ~78.7 fl) 1
• Typically shows 20-30% HbE on electrophoresis with elevated HbA2 (mean 3.4% vs normal 2.6%) 2
• Critical pitfall: Coexisting iron deficiency (present in 62% of children) substantially lowers hemoglobin and MCV, making the picture appear worse than the hemoglobinopathy alone 3
• These individuals require no specific treatment beyond addressing nutritional deficiencies

HbE Homozygotes (HbEE)

• Only slightly anemic with minimal clinical impact 3
• Shows predominantly HbE (>90%) with HbA2 around 4.4% 2
• May present with mild splenomegaly and target cells on peripheral smear 4
• Generally do not require transfusions

HbE/β-Thalassemia Compound Heterozygotes

• This is the clinically significant combination with severe anemia (mean Hb ~76.4 g/L) and marked microcytosis (MCV ~59.2 fl) 1
• Requires long-term transfusion therapy 3
• Can present with massive splenomegaly, iron overload, and splenic infarcts 4
• This genotype carries significant morbidity and mortality risk

Diagnostic Algorithm

When HbE is detected:

1. Quantify the HbE percentage:

   • <20% suggests HbE trait, especially if <19% which may indicate co-inherited α⁰-thalassemia 5
   • 20-30% typical for HbE trait

   • 90% suggests HbE homozygosity

2. Assess hematologic parameters:

   • Mild microcytosis (MCV 73-79 fl) with near-normal Hb → likely HbE trait
   • Severe microcytosis (MCV <60 fl) with significant anemia → suspect HbE/β-thalassemia 1

3. Screen for co-inherited conditions:

   • Check iron studies (ferritin, transferrin saturation) as iron deficiency is extremely common and confounds the picture 3
   • Consider α-thalassemia screening, particularly in Southeast Asian populations 5
   • Perform β-thalassemia mutation analysis if severe anemia present 1

4. Family studies and genetic counseling:

   • Essential for reproductive planning, especially when HbE/β-thalassemia is suspected 1
   • Prenatal diagnosis should be offered to at-risk couples

Key Clinical Pitfalls

Iron deficiency masking: The most common error is attributing all anemia to HbE when concurrent iron deficiency (from nutritional factors or parasitic infections) is the primary driver 3. Always evaluate and correct iron deficiency first.

Misidentification on electrophoresis: HbE migrates in the C/E zone on alkaline pH and can be confused with other variants. Capillary electrophoresis can mis-anchor when unusual variants are present 6. Confirm with acid pH electrophoresis or molecular testing when patterns are atypical.

Underestimating compound heterozygotes: The combination of HbE with β-thalassemia creates a severe phenotype that is vastly different from HbE trait alone. Missing this diagnosis delays critical transfusion support and iron chelation therapy 4.

Geographic and Population Context

HbE is the most prevalent hemoglobinopathy in the eastern Indian subcontinent and Southeast Asia 4, 3. In multi-ethnic populations like Malaysia, rare compound heterozygous states (e.g., HbE with other variants) can occur 7. Always consider ethnic background when interpreting results, as this guides the differential diagnosis and screening approach.